Method for expressing and purifying protein by using csq-tag
US-2024209046-A1 · Jun 27, 2024 · US
Fibroblast growth factor [FGF]
Fibroblast growth factor [FGF] · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/50 |
| Official title | Fibroblast growth factor [FGF] |
| Display label | Fibroblast growth factor [FGF] |
| Total patents | 462 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 29 |
| 2016 | 49 |
| 2017 | 51 |
| 2018 | 57 |
| 2019 | 47 |
| 2020 | 46 |
| 2021 | 40 |
| 2022 | 32 |
| 2023 | 40 |
| 2024 | 40 |
| 2025 | 25 |
| 2026 | 6 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Islet cell manufacturing compositions and methods of use
US-11945795-B2 · Apr 2, 2024 · US
FGF21 mutants comprising a mutation at position 98, 171 and/or 180
US-9493530-B2 · Nov 15, 2016 · US
Methods and compositions using a Klotho-FGF23 fusion polypeptide
US-9475857-B2 · Oct 25, 2016 · US
Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
US-9475856-B2 · Oct 25, 2016 · US
Chimeric fibroblast growth factor 21 proteins and methods of use
US-9464126-B2 · Oct 11, 2016 · US
Compositions and methods for osteogenic gene therapy
US-9458215-B2 · Oct 4, 2016 · US
Methods and compositions using Klotho-FGF fusion polypeptides
US-9458209-B2 · Oct 4, 2016 · US
Pharmaceutical composition for treating a metabolic syndrome
US-2016279199-A1 · Sep 29, 2016 · US
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
US-9434778-B2 · Sep 6, 2016 · US
Fgf21 mutants and uses thereof
US-2016244497-A1 · Aug 25, 2016 · US
Fibroblast growth factor 21 variant, composition , and uses thereof
US-9422353-B2 · Aug 23, 2016 · US
Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
US-2016206695-A1 · Jul 21, 2016 · US
Fusion proteins comprising FGF-21 and GLP-1R agonist
US-2016194371-A1 · Jul 7, 2016 · US
Fusion proteins for treating metabolic disorders
US-2016193297-A1 · Jul 7, 2016 · US
Methods of using compositions comprising variants and fusions of fgf19 polypeptides for reducing glucose levels in a subject
US-2016168216-A1 · Jun 16, 2016 · US
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
US-2016168221-A1 · Jun 16, 2016 · US
Compositions comprising variants and fusions of fgf19 polypeptides
US-2016168215-A1 · Jun 16, 2016 · US
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
US-2016168219-A1 · Jun 16, 2016 · US
Remodeling and glycopegylation of fibroblast growth factor (fgf)
US-2016158319-A1 · Jun 9, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/50?
- CPC C07K14/50 is the Cooperative Patent Classification code for “Fibroblast growth factor [FGF].”
- How many patents are filed under CPC C07K14/50 (Fibroblast growth factor [FGF])?
- Our database includes 462 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/50 growing?
- Publication counts under this code: 40 in 2024 vs 25 in 2025 (latest complete years).